scholarly article | Q13442814 |
P2093 | author name string | Kenneth McMartin | |
Dag Jacobsen | |||
Knut Erik Hovda | |||
P2860 | cites work | Fulminant ascending paralysis as a delayed sequela of diethylene glycol (Sterno) ingestion | Q78504651 |
Extremely slow formate elimination in severe methanol poisoning: a fatal case report | Q80337846 | ||
Kinetics of fomepizole in pregnant rats | Q84793217 | ||
Outbreak of acute renal failure in Panama in 2006: a case-control study | Q24646767 | ||
Fomepizole for ethylene glycol and methanol poisoning | Q28245655 | ||
Are calcium oxalate crystals involved in the mechanism of acute renal failure in ethylene glycol poisoning? | Q28262357 | ||
Adverse drug events associated with the antidotes for methanol and ethylene glycol poisoning: a comparison of ethanol and fomepizole | Q28287715 | ||
2013 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 31st Annual Report | Q30882807 | ||
Fomepizole for the treatment of methanol poisoning | Q31921338 | ||
Methanol poisoning and long term sequelae - a six years follow-up after a large methanol outbreak | Q33423222 | ||
Intermittent hemodialysis is superior to continuous veno-venous hemodialysis/hemodiafiltration to eliminate methanol and formate during treatment for methanol poisoning. | Q33840544 | ||
Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group | Q33855295 | ||
American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Ethylene Glycol Poisoning. Ad Hoc Committee | Q33875038 | ||
Severe ethylene glycol poisoning treated wtih fomepizole (4-methylpyrazole) | Q33962754 | ||
Osmol gaps revisited: normal values and limitations. | Q34061735 | ||
Fomepizole for the treatment of pediatric ethylene and diethylene glycol, butoxyethanol, and methanol poisonings | Q34123226 | ||
American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning | Q34148248 | ||
Severe methanol poisoning. Application of a pharmacokinetic model for ethanol therapy and hemodialysis | Q34227691 | ||
Methanol outbreak in Norway 2002-2004: epidemiology, clinical features and prognostic signs | Q34433918 | ||
Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning. Acute Renal Failure Investigation Team | Q34465188 | ||
Diglycolic acid is the nephrotoxic metabolite in diethylene glycol poisoning inducing necrosis in human proximal tubule cells in vitro | Q34631751 | ||
Diethylene glycol poisoning | Q34991269 | ||
Medication-associated diethylene glycol mass poisoning: a review and discussion on the origin of contamination | Q34992120 | ||
What Are the Adverse Effects of Ethanol Used as an Antidote in the Treatment of Suspected Methanol Poisoning in Children? | Q35122477 | ||
Long-term renal and neurologic outcomes among survivors of diethylene glycol poisoning | Q35991251 | ||
Current recommendations for treatment of severe toxic alcohol poisonings | Q35997305 | ||
1987 Annual report of the American Association of Poison Control Centers National Data Collection System | Q36455436 | ||
Acute experimental poisoning by diethylene glycol: acid base balance and histological data in male rats | Q36517621 | ||
Massive ethylene glycol ingestion treated with fomepizole alone-a viable therapeutic option | Q36549089 | ||
A systematic review of ethanol and fomepizole use in toxic alcohol ingestions | Q36616148 | ||
Expert opinion: fomepizole may ameliorate the need for hemodialysis in methanol poisoning | Q37284361 | ||
Fomepizole: a critical assessment of current dosing recommendations | Q37323969 | ||
Clinical, laboratory, diagnostic, and histopathologic features of diethylene glycol poisoning--Panama, 2006. | Q38179646 | ||
Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning: a systematic review and consensus statement | Q38286063 | ||
Diagnosis of toxic alcohols: limitations of present methods | Q38538412 | ||
A novel bedside diagnostic test for methanol poisoning using dry chemistry for formate | Q38981864 | ||
Methanol poisoning I. The role of formic acid in the development of metabolic acidosis in the monkey and the reversal by 4-methylpyrazole | Q39074137 | ||
Metabolism of pyrazole. Structure elucidation of urinary metabolites | Q39144239 | ||
Methanol poisoning: ocular toxicity produced by formate | Q39620837 | ||
Acute methyl alcohol poisoning. (A review of an outbreak of 89 cases) | Q40065273 | ||
Czech mass methanol outbreak 2012: epidemiology, challenges and clinical features | Q40231013 | ||
Long-term visual damage after acute methanol poisonings: Longitudinal cross-sectional study in 50 patients. | Q40312820 | ||
Standardized treatment of severe methanol poisoning with ethanol and hemodialysis | Q40347959 | ||
Methanol half-life during ethanol administration: implications for management of methanol poisoning. | Q40449296 | ||
Fomepizole versus ethanol in the treatment of acute methanol poisoning: Comparison of clinical effectiveness in a mass poisoning outbreak | Q40799398 | ||
Non-linear kinetics of 4-methylpyrazole in healthy human subjects. | Q41896817 | ||
Fluctuations in serum ethanol concentration in the treatment of acute methanol poisoning: a prospective study of 21 patients. | Q42158081 | ||
Methanol mass poisoning in Iran: role of case finding in outbreak management. | Q42209860 | ||
Role of tissue metabolite accumulation in the renal toxicity of diethylene glycol | Q42728584 | ||
Inhibition of metabolism of diethylene glycol prevents target organ toxicity in rats | Q43041981 | ||
Renal toxicity of ethylene glycol results from internalization of calcium oxalate crystals by proximal tubule cells | Q43237329 | ||
Treatment of acute methanol poisoning with fomepizole. | Q43712089 | ||
Childhood methanol ingestion treated with fomepizole and hemodialysis | Q43753684 | ||
Oral administration of fomepizole produces similar blood levels as identical intravenous dose | Q43938790 | ||
Epidemic Methanol Poisoning: Clinical and Biochemical Analysis of a Recent Episode | Q44032941 | ||
Ethanol therapy for methanol poisoning: duration and problems | Q44190351 | ||
Inhalational methanol toxicity in pregnancy treated twice with fomepizole | Q44312977 | ||
Methanol contamination of Romanian home-distilled alcohol | Q44368046 | ||
An epidemic of antifreeze poisoning | Q44590192 | ||
Anion and osmolal gaps in the diagnosis of methanol poisoning: clinical study in 28 patients | Q44969379 | ||
Treatment of severe pediatric ethylene glycol intoxication without hemodialysis | Q45054996 | ||
Effect of ethanol on ethylene glycol oxidation by mammalian liver enzymes. | Q45175568 | ||
The pharmacokinetics of methanol in the presence of ethanol: a case study | Q46089431 | ||
Ethanol: tastes great! Fomepizole: less filling! | Q46262626 | ||
Delayed neurologic sequelae resulting from epidemic diethylene glycol poisoning | Q46498085 | ||
Methanol and formate kinetics during treatment with fomepizole | Q46611672 | ||
Increased serum formate in the diagnosis of methanol poisoning | Q46707619 | ||
Fomepizole may change indication for hemodialysis in methanol poisoning: prospective study in seven cases | Q46714203 | ||
Risk factors related to poor outcome after methanol poisoning and the relation between outcome and antidotes--a multicenter study. | Q46876693 | ||
Methanol mass poisoning in Estonia: outbreak in 154 patients | Q48239106 | ||
Ethylene glycol poisoning: experiences from an epidemic in Sweden | Q48583901 | ||
Studies on ethylene glycol poisoning: one patient - 154 admissions | Q48810064 | ||
Massive ethylene glycol poisoning triggers osmotic demyelination syndrome | Q48916549 | ||
Studies on ethylene glycol poisoning. | Q49041237 | ||
Kinetics and metabolism of fomepizole in healthy humans. | Q51372194 | ||
Hemodialysis for methanol intoxication. | Q52108873 | ||
The osmolal gap in renal failure. | Q52706887 | ||
Acetone in diabetic ketoacidosis. | Q53942402 | ||
The use of an ethanol- and phosphate-enriched dialysate to maintain stable serum ethanol levels during haemodialysis for methanol intoxication. | Q54207998 | ||
Methanol metabolism in the monkey | Q54403252 | ||
Fomepizole in treatment of uncomplicated ethylene glycol poisoning. | Q55033287 | ||
Human liver alcohol dehydrogenase: inhibition by pyrazole and pyrazole analogs | Q68598844 | ||
Increased osmolal gap in alcoholic ketoacidosis and lactic acidosis | Q68919383 | ||
Comparison of the effects of ethanol and 4-methylpyrazole on the pharmacokinetics and toxicity of ethylene glycol in the dog | Q69767529 | ||
Clinical Studies of Alcoholic Ketoacidosis | Q69767845 | ||
Considerations for the treatment of ethylene glycol poisoning based on analysis of two cases | Q70191173 | ||
Studies on methanol poisoning | Q70467613 | ||
Glycolate causes the acidosis in ethylene glycol poisoning and is effectively removed by hemodialysis | Q70728199 | ||
Pulmonary excretion of methanol in man | Q71117693 | ||
4-methylpyrazole monitoring during haemodialysis of ethylene glycol intoxicated patients | Q71149790 | ||
Ethylene glycol poisoning: pharmacokinetics during therapy with ethanol and hemodialysis | Q71373094 | ||
Studies on the metabolic interactions between 4-methylpyrazole and methanol using the monkey as an animal model | Q71496472 | ||
4-Methylpyrazole (4-MP) is effectively removed by haemodialysis in the pig model | Q71503362 | ||
Predictive value of serum osmolality in shock following major trauma | Q71688526 | ||
Osmolal and anion gaps in patients admitted to an emergency medical department | Q72674286 | ||
Intravenous 4-methylpyrazole as an antidote for diethylene glycol and triethylene glycol poisoning: a case report | Q73000982 | ||
Methanol poisoning during late pregnancy | Q73272791 | ||
Osmolal gap in alcoholic ketoacidosis | Q73566030 | ||
Childhood diethylene glycol poisoning treated with alcohol dehydrogenase inhibitor fomepizole and hemodialysis | Q73740110 | ||
Treatment of acute methanol intoxication with hemodialysis using an ethanol-enriched, bicarbonate-based dialysate | Q73782151 | ||
Preparation of ethanol-enriched, bicarbonate-based hemodialysates | Q74459821 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 505-515 | |
P577 | publication date | 2015-11-09 | |
P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
P1476 | title | Antidotes for poisoning by alcohols that form toxic metabolites | |
P478 | volume | 81 |
Q93008884 | Acute toxic kidney injury |
Q37322623 | Case Report of a Fatal Antifreeze Ingestion with a Record High Level and Impressive Renal Crystal Deposition. |
Q90429601 | Early dialysis in a rare case of combined toxic alcohols ingestion |
Q38668658 | Intermittent versus continuous renal replacement therapy in acute methanol poisoning: comparison of clinical effectiveness in mass poisoning outbreaks |
Q89481558 | Methanol as an Unlisted Ingredient in Supposedly Alcohol-Based Hand Rub Can Pose Serious Health Risk |
Q40273035 | Positive serum ethanol concentration on admission to hospital as the factor predictive of treatment outcome in acute methanol poisoning |
Q92606177 | The Diagnosis and Management of Toxic Alcohol Poisoning in the Emergency Department: A Review Article |
Q35974818 | The Methanol Poisoning Outbreaks in Libya 2013 and Kenya 2014 |
Q42591705 | Therapeutics in clinical toxicology: in the absence of strong evidence how do we choose between antidotes, supportive care and masterful inactivity |
Q50089562 | Toxic alcohol diagnosis and management: an emergency medicine review |
Search more.